PDCD1 and neoplasm: Indeed, there has been a number of clinical reports showing the augmented abscopal effect in combination with PD-1/PD-L1 inhibitors, which is characterized by the tumor regression of untreated metastatic lesions following local radiotherapy [9], [10], [11].